Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis

Author:

Lambertini Matteo12ORCID,Blondeaux Eva13,Bruzzone Marco4ORCID,Perachino Marta12ORCID,Anderson Richard A.5ORCID,de Azambuja Evandro6ORCID,Poorvu Philip D.7ORCID,Kim Hee Jeong8,Villarreal-Garza Cynthia910ORCID,Pistilli Barbara11ORCID,Vaz-Luis Ines11ORCID,Saura Cristina12ORCID,Ruddy Kathryn J.13ORCID,Franzoi Maria Alice11ORCID,Sertoli Chiara1,Ceppi Marcello4ORCID,Azim Hatem A.9ORCID,Amant Frederic1415ORCID,Demeestere Isabelle16ORCID,Del Mastro Lucia13ORCID,Partridge Ann H.7ORCID,Pagani Olivia17,Peccatori Fedro A.18ORCID

Affiliation:

1. Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy

2. Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy

3. Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy

4. Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

5. MRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom

6. Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium

7. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA

8. Department of Surgical Oncology, Asan Medical Center, Seoul, Korea

9. Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico

10. Department of Breast Tumors, Instituo Nacional de Cancerologia, Mexico City, Mexico

11. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France

12. Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

13. Division of Medical Oncology, Mayo Clinic, Rochester, MN

14. Netherlands Cancer Institute and Amsterdam University Medical Centers, Amsterdam, the Netherlands

15. Department of Oncology, KU Leuven, Leuven, Belgium

16. Fertility Clinic, CUB-Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium

17. Geneva University Hospitals, European School of Oncology, Geneva, Switzerland

18. Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy

Abstract

PURPOSE Many patients and physicians remain concerned about the potential detrimental effects of pregnancy after breast cancer (BC) in terms of reproductive outcomes and maternal safety. This systematic review and meta-analysis aimed at providing updated evidence on these topics. METHODS A systematic literature review was conducted to identify studies including patients with a pregnancy after BC (PROSPERO number CRD42020158324). Likelihood of pregnancy after BC, their reproductive outcomes, and maternal safety were assessed. Pooled relative risks, odds ratios (ORs), and hazard ratios (HRs) with 95% CIs were calculated using random effects models. RESULTS Of 6,462 identified records, 39 were included involving 8,093,401 women from the general population and 112,840 patients with BC of whom 7,505 had a pregnancy after diagnosis. BC survivors were significantly less likely to have a subsequent pregnancy compared with the general population (relative risk, 0.40; 95% CI, 0.32 to 0.49). Risks of caesarean section (OR, 1.14; 95% CI, 1.04 to 1.25), low birth weight (OR, 1.50; 95% CI, 1.31 to 1.73), preterm birth (OR, 1.45; 95% CI, 1.11 to 1.88), and small for gestational age (OR, 1.16; 95% CI, 1.01 to 1.33) were significantly higher in BC survivors, particularly in those with previous chemotherapy exposure, compared with the general population. No significantly increased risk of congenital abnormalities or other reproductive complications were observed. Compared to patients with BC without subsequent pregnancy, those with a pregnancy had better disease-free survival (HR, 0.66; 95% CI, 0.49 to 0.89) and overall survival (HR, 0.56; 95% CI, 0.45 to 0.68). Similar results were observed after correcting for potential confounders and irrespective of patient, tumor, and treatment characteristics, pregnancy outcome, and timing of pregnancy. CONCLUSION These results provide reassuring evidence on the safety of conceiving in BC survivors. Patients' pregnancy desire should be considered a crucial component of their survivorship care plan.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3